← Back
$RARE All transactions

Ultragenyx Pharmaceutical Inc.

A

$ Value

$0

Shares

132,693

Price

$0

Filed

Apr 20

Insider

Name

KAKKIS EMIL D

Title

President & CEO

CIK

0001248093

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-16

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

132,693

Footnotes

Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date | Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. | Amount of securities beneficially owned following reported transaction reflects the contribution of an aggregate of 400,000 shares previously owned indirectly by the reporting person to two grantor retained annuity trusts (each, a "GRAT"). | On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Filing Info

Accession No.

0001193125-26-164308

Form Type

4

Issuer CIK

0001515673

KAKKIS EMIL D's History

Date Ticker Type Value
2026-04-16 RARE A $0
2026-04-16 RARE A $0

Other Insiders at RARE (90d)

Insider Bought Sold Last
KAKKIS EMIL D
President & CEO
2026-04-16
Huang Dennis Karl
See Remarks
2026-04-16
Pinion John Richard
See Remarks
2026-04-16
Crombez Eric
EVP and Chief Medical Officer
2026-04-16
Parschauer Karah Herdman
EVP and Chief Legal Officer
2026-04-16
Harris Erik
EVP & Chief Commercial Officer
2026-04-16
Horn Howard
Chief Financial Officer
$98K 2026-04-16